BusinessLux Research Releases In-Depth Benchmark Study on Sugar Replacement TechnologiesBy Nasdaq OMXApr 4, 2018, 4:00 PM UTC
BusinessUpper Street Marketing, Inc. Announces an LOI for the Acquisition of the Learn2Grow Division of Preferred Commerce, Inc.By Nasdaq OMXFeb 7, 2018, 11:50 PM UTC
BusinessCrinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s DiseaseBy Nasdaq OMXSep 6, 2017, 1:01 PM UTC
Business2017 National Guild of Hypnotists Convention Emphasizes the Power of HypnosisBy Nasdaq OMXAug 2, 2017, 2:10 PM UTC
BusinessCrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity and Type 2 Diabetes drug discoveryBy Nasdaq OMXJul 6, 2017, 12:00 PM UTC
BusinessNanotherapeutic technology could safely, effectively convert bad fat to good fat, treat obesityBy Nasdaq OMXMay 24, 2017, 2:04 PM UTC
BusinessNanotherapeutic technology could safely, effectively convert bad fat to good fat, treat obesityBy Nasdaq OMXMay 24, 2017, 2:04 PM UTC
BusinessNanotherapeutic technology could safely, effectively convert bad fat to good fat, treat obesityBy Nasdaq OMXMay 24, 2017, 2:04 PM UTC
